Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Avapro - labeled renal guidance
Product / population
Irbesartan (Avapro), adult oral tablets for hypertension
Renal method
Intravascular volume or salt depletion; no numerical renal cutoff for this starting dose
Source revision
DailyMed SPL version 22, effective 2026-08-24; posted Aug 31, 2026
DailyMed / product prescribing information · Irbesartan (Avapro), adult oral tablets for hypertension
Renal method: Intravascular volume or salt depletion; no numerical renal cutoff for this starting dose Source date: DailyMed SPL version 22, effective 2026-08-24; posted Aug 31, 2026 Retrieved: 2026-11-07
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Renal guidance: Dosage in volume- and salt-depleted patients; 5.2 and 5.3
When intravascular volume or salt is depleted, including in some patients on hemodialysis or receiving intensive diuresis, start at 75 mg once daily. Assess volume status and blood pressure first. This lower starting dose addresses depletion; it is not a dose to repeat after every dialysis session.
RDM73-avapro-official-1 · Source locator: Renal guidance: Dosage in volume- and salt-depleted patients; 5.2 and 5.3
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
